COMT as a Drug Target for Cognitive Functions and Dysfunctions

E-ISSN： 1996-3181|11|3|209-221

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.3, 2012-05, pp. : 209-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can COMT Inhibitors Improve Cognitive Functions in Patients with Parkinson's Disease?

By Meco G. Alessandri A.

CNS Drugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 227-232

Adis International

Access to resources Recommend Favorite

Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 193-194

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite

Pontine regulation of pelvic viscera: pharmacological target for pelvic visceral dysfunctions

By Valentino R.J. Miselis R.R. Pavcovich L.A.

Trends in Pharmacological Sciences, Vol. 20, Iss. 6, 1999-06 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite

Drug target central

By Harland Lee Gaulton Anna

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 857-872

Informa Healthcare

Access to resources Recommend Favorite